Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
17 results
D3.260 - Shiitake-Induced Flagellate Dermatitis: Case Series from Kazakhstan
D3.261 - Orphan Diseases In Allergology - Melkersson-Rosenthal Syndrome
D3.264 - Delayed Type Hypersensitivity Injection Site Reaction Induced By Liraglutide
D3.265 - Gleish syndrome: A case report
D3.266 - Component-Resolved Delayed Hypersensitivity to Piperacillin/Tazobactam and Clavulanic Acid Despite Structural Divergence
D3.267 - Statistics of Contributing Factors to Atopic Dermatitis in Children
D3.258 - Not just a rash: a delayed diagnosis of allopurinol-induced dress syndrome
D1.391 - Pharmacist-led Risk-based β-Lactam Challenges in Patients with Penicillin Allergy: Impact on Antibiotic Days
D1.381 - Antibiotic Allergy De-labelling in Children: Outcomes of Drug Provocation Testing and Feasibility of Non-Specialist Pathways to de-labelling
D1.382 - Vitamin K–Induced Anaphylaxis: A Case Series from a Tertiary Hospital in Manila, Philippines (2024–2025)
D1.384 - Safe Sulfonamide Delabeling in HIV-Negative Adults: Real-World Evidence with TMP-SMX Oral Challenge and SULF-FAST
D1.385 - Lamotrigine-induced Stevens-Johnson syndrome in a pediatric patient with Takayasu arteritis: the steroid paradox
D1.387 - Long-term Follow-up Outcomes of Patients Undergoing Desensitization for Non-Immediate Hypersensitivity Reactions Associated with Lenalidomide
D1.388 - Aspirin maintenance after boost with dupilumab in aspirin-exacerbated respiratory disease
D1.390 - Hypersensitivity Reactions to Biological Agents in a Tertiary Hospital: A 3.5-Year Retrospective Study
D1.392 - Drug-Induced Hypersensitivity Syndrome Associated with β-Lactams and Hemophagocytic Lymphohistiocytosis: Overlapping Disorders or a Causal Relationship?
D1.393 - Safety of Aspirin Oral Provocation in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Download the app
The congress at your fingertips
Available on
Download